LivingGLP1
Study S000385

The Effects of Faecal Microbiota Transplantation on Beta Cell Preservation in Patients With Newly Diagnosed Type 1 Diabetes

Registration

Registration
NCT05622123
Acronym
BetaFIT
Study type
INTERVENTIONAL
Phase
PHASE2
Masking
NONE
Status
UNKNOWN
Enrollment
20
Start
2023-02-23
Primary completion
2024-02-28
Lead sponsor
Radboud University Medical Center
Conditions
Type 1 Diabetes
Interventions
DRUG:68Ga-NODAGA-Exendin-4
Results posted
FALSE

Registered primary outcomes

  • Correlation between residual beta cell mass and function [1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.